A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. in the Treatment of Subjects With Symptomatic Seasonal Allergic Rhinitis (SAR).
Phase of Trial: Phase IV
Latest Information Update: 16 May 2017
At a glance
- Drugs Desloratadine; Fexofenadine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 23 Nov 2008 New trial record.